
    
      PROTOCOL OUTLINE: This is a multicenter study. Patients undergo total body irradiation on day
      0, followed by allogeneic bone marrow transfusion. Patients also receive fludarabine IV daily
      and cyclosporine IV twice a day on days -1 to 1. Patients then receive oral cyclosporine on
      days 1-90, and oral mycophenolate mofetil twice a day on days 0-27.

      Patients are followed for 100 days, monthly for 6 months and then annually for 2 years.
    
  